N/A
N=240
Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk
Suicidal Ideation · Suicide, Attempted
Bottom Line
View on ClinicalTrials.gov: NCT03825588 ↗Enrolled (actual)
240
Serious AEs
0.4%
Results posted
Jan 2025
Primary outcome: Primary: Participants With Actual Suicide Attempts as Defined by Columbia Suicide Severity Rating Scale (C-SSRS) — 6; 11; 12; 10 Participants — p=0.71
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ASAP (As Safe As Possible) (Behavioral); BRITE smart phone app (Behavioral); TAU (treatment as usual) (Behavioral)
- Age
- Pediatric · 12+ yrs
- Sex
- All
- Sponsor
- University of Texas Southwestern Medical Center
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participants With Actual Suicide Attempts as Defined by Columbia Suicide Severity Rating Scale (C-SSRS) |
6; 11; 12; 10 | 0.71 |
| PRIMARY Suicidal Events |
12; 23; 18; 17 | 0.19 |
Summary
In this 2-site study, University of Texas Southwestern Medical Center (UTSW) and Western Psychiatric Institute and Clinic (WPIC), the investigators will conduct a randomized clinical trial (RCT) in 240 psychiatrically hospitalized suicidal adolescents, examining the single and additive effects of two components of an inpatient unit intervention for suicidal adolescents, As Safe As Possible (ASAP), which focuses on emotion regulation and safety planning, and an emotion regulation/safety plan phone app (BRITE).
Eligibility Criteria
Inclusion Criteria
- Youth admitted to the inpatient unit at either site for a recent suicide attempt or significant suicidal ideation with a plan or intent.
- The youth and parent are able to complete assessments in English, and the youth is able to complete therapy.
Exclusion Criteria
- The youth currently exhibits psychosis.
- The youth currently exhibits mania.
- The youth is currently <85% of their ideal body weight.
- The youth is intellectually incapable of completing the study, e.g. has an intelligence quotient (IQ) < 70.
Data sourced from ClinicalTrials.gov (NCT03825588). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.